Johnson Pharmacare Limited has announced the resignation of two directors from its board, both effective January 21, 2026. The pharmaceutical company disclosed these changes in compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Director Resignations Overview

The company experienced simultaneous departures from its board leadership on January 21, 2026. Both resignations were attributed to personal and unavoidable reasons, with formal documentation submitted to BSE Limited.

Regulatory Compliance and Confirmations

Johnson Pharmacare Limited confirmed receipt of formal resignation letters from both directors. The company stated that it received confirmation from both Mr. Rajender Parsad and Ms. Parul Agrawal that there were no other material reasons for their resignations beyond those provided in their formal submissions.

The resignations were processed in accordance with the provisions of the Companies Act, 2013, and SEBI (LODR) Regulations. Additional Director Umesh Kumar (DIN: 07015921) signed the disclosure documents on behalf of the Board of Directors.

Directors' Other Commitments

Both resigning directors maintain positions with other listed entities. The disclosure revealed their external directorship commitments:

Company Information

Johnson Pharmacare Limited operates with its registered office located at Office No. 4-D, Fourth Floor Vardan Tower, Lakhudi Circle, Near Sardar Patel Stadium, Navrangpura, Ahmedabad, Gujarat. The company's corporate office is situated at 1002 10th Floor, Vikram Tower, Rajendra Place, New Delhi. The company trades on BSE under scrip code 532154 with ISIN INE560F01022.

The formal disclosure documents were submitted to BSE Limited's Department of Corporate Service, ensuring compliance with all regulatory requirements for director changes. Both resignations became effective during working hours on January 21, 2026, marking a significant change in the company's board composition.

Johnson Pharmacare Limited has announced the resignation of its statutory auditor M/s Rishi Sekhri and Associates Chartered Accountants, effective January 15, 2026. The company disclosed this development to the Bombay Stock Exchange under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirement) Regulations, 2015.

Auditor Resignation Details

The auditing firm M/s Rishi Sekhri and Associates Chartered Accountants (Membership No. 126656) submitted their resignation letter citing preoccupation with other assignments as the primary reason for stepping down from their role as statutory auditor.

Audit Tenure and Background

The regulatory filing reveals the complete timeline of the auditor's association with Johnson Pharmacare Limited. M/s Rishi Sekhri and Associates were originally appointed as statutory auditors on September 4, 2017, with their term scheduled to expire on March 31, 2024.

Regulatory Compliance and Documentation

Johnson Pharmacare Limited has fulfilled all regulatory requirements regarding the auditor resignation. The company's Additional Director Umesh Kumar (DIN: 07015921) signed the disclosure documents on January 15, 2026, from New Delhi.

The auditing firm has provided a no-objection certificate stating they have no concerns regarding the appointment of another chartered accountant as the company's statutory auditor. The resignation letter confirms that no material concerns or issues prompted the resignation beyond the stated reason of other professional commitments.

Company Information

Johnson Pharmacare Limited operates with CIN L51100GJ1994PLC022388 and maintains its registered office at Office No. 4-D, Fourth Floor Vardan Tower, Lakhudi Circle, Near Sardar Patel Stadium, Navrangpura, Ahmedabad, Gujarat. The company trades on the Bombay Stock Exchange under scrip code 532154 with ISIN INE560F01022.

The company will need to appoint a new statutory auditor to fill the vacancy created by this resignation, following the prescribed regulatory procedures for auditor appointments in listed companies.